Human Cysticercosis
The Serological Survey for Human Cysticercosis Prevalence in Mbulu District, Tanzania
5
A Review of Human Cysticercosis and Diagnostic Challenges in Endemic Resource Poor Countries
8
Serodiagnosis of Human Cysticercosis by Using Antigens from Vesicular Fluid of Taenia crassicepsCysticerci
5
Immunodiagnosis of human cysticercosis (Taenia solium) with antigens purified by monoclonal antibodies
5
Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe
14
The status and health burden of neurocysticercosis in Mbulu district, northern Tanzania
5
Taenia solium taeniosis/cysticercosis and the co distribution with schistosomiasis in Africa
14
Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin
9
Current Status of Prevalence, Possible Control and Risk Factors Associated with Porcine Cysticercosis from Endemic Countries in Africa
28
Taenia solium Cysticercosis in Sub Saharan Africa: Perspectives for a Better Control
17
Development and Evaluation of a Magnetic Immunochromatographic Test To Detect Taenia solium, Which Causes Taeniasis and Neurocysticercosis in Humans
7
Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe
11
How to eliminate taeniasis/cysticercosis: porcine vaccination and human chemotherapy (Part 2)
14
Assessing the impact of intervention strategies against Taenia solium cysticercosis using the EPICYST transmission model
14
Immunoglobulin E and G4 antibodies in cysticercosis
5
Taeniasis and cysticercosis due to Taenia solium in Japan
6
First case of peritoneal cysticercosis in a non human primate host (Macaca tonkeana) due to Taenia martis
5
TLR2 Mediates Immunity to Experimental Cysticercosis
11
Cerebral Cysticercosis: Treatment With Praziquantel
6
Uncertainties in the diagnosis of brain cysticercosis
12